The response to double-dose hepatitis B vaccination in patients with HIV

Objectives: Prevention of hepatitis B virus (HBV) infection is necessary for patients with human immunodeficiency virus (HIV), since co-infection is associated with increased in mortality. The aim of this study was to investigate response to double-dose HBV vaccine in patients with HIV. Methods: A total of 149 patients with HIV were retrospectively evaluated. Sixty-eight patients who were HBV seronegative and administered double-dose HBV vaccine were included in the study. According to anti HBs levels, patients were evaluated in three groups: < 10 mIU/mL, 10-100 mIU/mL and ≥ 100 mIU/mL. Age, sex, transmission route, smoking, alcohol-substance abuse, comorbidities, CD4+ T cells counts and HIV viral load were compared in three groups. Results: The rate of response to HBV vaccination (anti HBs ≥ 10 mIU/mL) was 69.1%. Age was statistically significantly higher in the anti HBs < 100 mIU/mL group than in the anti HBs >100 mIU/mL group. The level of anti HBs was statistically significantly lower in patients with a CD4+ T cell count < 200 cells/μL (< 100 mIU/mL). Conclusions: The use of high-dose vaccine is a necessity as well as revaccination to improve vaccine immunogenicity in patients with HIV. In our study, low CD4+ T lymphocyte count and older age were found to have a negative effect on vaccine response.


1. Pasricha N, Datta U, Chawla Y, Singh S, Arora SK, Sud A, et al. Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine. BMC Infect Dis 2006; 6:65.

2. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, et al.; Multicenter AIDS Cohort Study. HIV-1, hepatitis B, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS). Lancet 2002;360:1921-6.

3. Overton ET, Sungkanuparph S, Powderly WG, Seyfried W, Groger RK, Aberg JA. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis 2005; 41:1045-3.

4. Van Herck K, Van Damme P, Thoelen S, Meheus A. Long-term persistence of antiHBs after vaccination with a recombinant DBA yeast derived hepatitis B vaccine: 8 year results. Vaccine 1998;16:1933-5.

5. European AIDS Clinical Society Treatment Guidelines. Available at Accessed: October 2017.

6. British HIV Association guidelines on the use of vaccines in HIV-positive adults 2015. Available at Accessed: November 2015.

7. İnci A, Fincancı M. [Antibody response to a standard dose of hepatitis B vaccine in HIV-infected patients]. Klimik Journal 2014;27:12-4. [Article in Turkish]

8. Kellerman SE, Hanson DL, McNaghten AD, Fleming PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 2003;188:571-7.

9. Kim HN, Harrington RD, Crane HM, Dhanireddy S, Dellit TH, Spach DH. Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations. Int J STD AIDS 2009;20:595-5.

10. Flynn PM, Cunningham CK, Rudy B, Wilson CM, Kapogiannis B, Worrell C, et al. Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens. J Acquir Immune Defic Syndr 2011;56:325-7.

11. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999;29:1306-4.

12. Martin-Carbonero L, Poveda E. Hepatitis B virus and HIV infection. Semin Liver Dis 2012;32:1149.

13. Thio CL. Hepatitis B in the human immunodeficiency virusinfected patient: epidemiology, natural history, and treatment. Semin Liver Dis 2003;23:125-11.

14. Bodsworth N, Cooper D, Donovan B. The influence of HIV1 infectionon the development of hepatitis B virus carrier state. J Infect Dis 1991;163:1138-2.

15. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, et al. Interactions between HIV and hepatitis B in homosexual men: effects on the natural history of infection. AIDS 1997;11:597-606.

16. Atalay S, Kış TT, Sönmez U, Köse Ş. Hepatitis B and C seroprevalence in patients with human immunodeficiency virus/acquired immune deficiency syndrome at tertiary care hospital in Izmir. Viral Hepat J 2018;24:3-6.

17. HahnéSJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Laar Mv. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis 2013;13:181.

18. İ̇nci A, Fincancı M, Soysal F. HIV/HBV co-infected cases. J Clin Anal Med 2015;6:439-3.

19. Wong E, Bodsworth NJ, Slade MA, Mulhall BP, Donovan B. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS 1996;7:490-4.

20. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis 1999;179:489-3.

21. Cornejo-Juárez P, Volkow-Fernández P, Escobedo-López K, Vilar-Compte D, Ruiz-Palacios G, Soto-Ramírez LE. Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses. AIDS Res Ther 2006;3:9.

22. Tedaldi EM, Baker RK, Moorman AC Wood KC, Fuhrer J, McCabe RE, et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 2004;38:1478-6.

23. Rey D, Krantz V, Partisani M, Schmitt MP, Meyer P, Libbrecht E, et al. Increasing the number of hepatitis B injections augments antiHBs response rate in HIV infected patients. Effect on viral load. Vaccine 2000;18:1161-5.

24. Fonseca MO, Pang LW, de Paula Cavalheiro N, Barone AA, Heloisa Lopes M. Randomized trial of recombinant hepatitis B vaccine in HIV infected adult patients comparing a standard dose to a double dose. Vaccine 2005;23:2902-8.

25. Hoebe CJ, Vermeiren AP, Dukers-Muijrers NH. Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous nonresponders. Vaccine 2012;30:6734-7.

26. Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs Standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA 2011;305:1432-40.

27. Whitaker JA, Rouphael NG, Edupuganti S, Lai L, Mulligan MJ. Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect Dis 2012;12:966-10.

28. Ni JD, Xiong YZ, Wang XJ, Xiu LC. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta analysis. Int J STD AIDS 2013;24:117-5.

29. De Vries-Sluijs TE, Hansen BE, van Doornum GJ, Springeling T, Evertsz NM, de Man RA, et al. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV infected patients. J Infect Dis 2008;197:292-4.

30. Potsch DV, Oliveira ML, Ginuino C, Miguel JC, Oliveira SA, Silva EF, et al. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects. Vaccine 2010;28:1447-3.


The European Research Journal
  • ISSN: 2149-3189
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 2015


Sayıdaki Diğer Makaleler

Thiol/disulphide balance and ischemia modified albumin levels in relapsed brucellosis patients


Rubella immunity in native Turkish and Syrian immigrant pregnant women between 2010-2018


Arthroscopic treatment and mid-term results of suprapatellar plica syndrome: a single-center experience of 14 cases


The difference between gender in terms of nomophobia in Turkey: a meta-analysis


Effects of microRNAs in hypertension disease


A retrospective investigation of the effect of tranexamic acid application and tourniquet duration on postoperative bleeding amount in patients undergoing total knee arthroplasty

Mustafa Onur KARACA, Abdullah MERTER, Kerem BAŞARIR, Mehmet Bahaddin GÜZEL

Validity and reliability study of the vaccine hesitancy scale in Turkish sample


Analysis of unplanned revisits and readmissions: results of the General Surgery clinic in a private hospital


Evaluation of anesthetic approaches to surgical patients during early COVİD-19 pandemic

Ümran KARACA, Filiz ATA, Canan YILMAZ, Ayşe Neslihan BALKAYA, Tuğba ONUR

Is tocilizumab effective in cytokine release syndrome in patients diagnosed with COVID-19?: a retrospective preliminary study

Gülbahar ÇALIŞKAN, Serra TOPAL, Ayça SAYAN, Nuri Burkay SOYLU